PLAKOUS THERAPEUTICS
Plakous Therapeutics, a human biologics company that specializes in restorative and regenerative healing. The company advances in regenerative healing by manufacturing bio-therapeutics from the post-delivery human placenta. It establishes a safe and effective therapeutic platform to promote and sustain healing using the placental cytokines and growth factors that orchestrate fetal development and also allow the body to heal itself. Seth Tomblyn and Scott Washburn co-founded the company in 2016 and Headquartered in Winston Salem, North Carolina.
PLAKOUS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Winston Salem, North Carolina, United States
Country:
United States
Website Url:
http://www.plakoustherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
336-782-3106
Email Addresses:
[email protected]
Total Funding:
3.66 M USD
Technology used in webpage:
COVID-19 Fastly Hosted
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Cidara Therapeutics
Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Founder
Investors List
Altis Biosystems
Altis Biosystems investment in Grant - Plakous Therapeutics
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Grant - Plakous Therapeutics
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Debt Financing - Plakous Therapeutics
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Grant - Plakous Therapeutics
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) investment in Grant - Plakous Therapeutics
One North Carolina Small Business Program
One North Carolina Small Business Program investment in Grant - Plakous Therapeutics
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) investment in Grant - Plakous Therapeutics
Official Site Inspections
http://www.plakoustherapeutics.com
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Plakous Therapeutics"
Plakous Therapeutics Company Profile 2024: โฆ
Www.plakoustherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 755 Highland โฆSee details»
Plakous Therapeutics - Crunchbase Company Profile โฆ
Organization. Plakous Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Plakous Therapeutics Company Profile | Management and
Www.plakoustherapeutics.com . Plakous Therapeutics Profile and History. Plakous Therapeutics is a biotherapeutic company dedicated to researching and developing placenta derived โฆSee details»
Plakous Therapeutics | Seed
Plakous Therapeutics developed a patented platform biotherapeutic to prevent the rare pediatric disease, necrotizing enterocolitis, and a follow-on indication for osteoarthritis.See details»
PLAKOUS THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PLAKOUS THERAPEUTICS, INC. of Pfafftown, NC. Get the latest business insights from Dun & Bradstreet.See details»
Plakous Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Plakous Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Technology Platform:Biological products, Drug:Protego-PD.See details»
Plakous Therapeutics - Overview, News & Similar companies
Plakous Therapeutics Awarded Phase II SBIR Grant from NIH to Continue Development of Therapies for Necrotizing Enterocolitis WINSTON-SALEM, N.C., Aug. 10, 2021 /PRNewswire/ โฆSee details»
Plakous Therapeutics - Org Chart, Teams, Culture
View Plakous Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Plakous Therapeutics LLC - VentureRadar
Website: http://www.plakoustherapeutics.com. Plakous Therapeutics is developing biotherapeutics from post-delivery placenta to promote regenerative healing for ...See details»
Plakous Therapeutics - LinkedIn
Plakous Therapeutics | 352 followers on LinkedIn. Healing After Birth. Developing cell free, placenta powered bio-therapeutics to drive in-situ regenerative healing.See details»
Board of Directors - Plakous Therapeutics
Stay Informed. Join our mailing list to keep up to date on new developments and progress.See details»
Plakous Therapeutics, Inc. (Plakous Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
For more information please visit the company's website at plakoustherapeutics.com. Disclaimer: Research reported in this publication was supported by the Eunice Kennedy Shriver National โฆSee details»
Plakous Therapeutics Inc Overview - Salary.com
Discover essential details about Plakous Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»
Contact Us - Plakous Therapeutics
Contact Us Our expert team can help answer any questions you may have. Get in touch today to learn more about Plakous Therapeutics.See details»
Plakous Therapeutics LLC - VentureRadar
Similar Companies: Ocis Biotechnology Inc. USA n/a Ocis Biotechnology is a regenerative medicine company that specializes in epigenetic modulation for tissue regeneration, repair and โฆSee details»
Plakous Therapeutics Announces New Funding to Support โฆ
For more information, please visit the companyโs website at plakoustherapeutics.com. ### Author: Scott Washburn Created Date: 7/5/2022 11:09:36 AM ...See details»
Canadian health plans, pharma firm agree on terms to fund costly ...
23 hours ago An organization representing Canada's public drug plans has come to a deal with a pharmaceutical company over a cutting-edge means of treating prostate cancer, bringing โฆSee details»
Behind Our Science - Plakous Therapeutics
Necrotizing Enterocolitis. Our first clinical target is preventing necrotizing enterocolitis (NEC), a rare pediatric disease complicated by prematurity that affects 6.2% of the 52,000 premature โฆSee details»
News - Plakous Therapeutics
FDA Designations. Plakous Therapeutics, Inc. has been granted orphan drug and rare pediatric disease designations for its human placental extract, Protego-PDTM for the prevention of โฆSee details»
Plakous Therapeutics extends research through agreement with โฆ
Aug 25, 2020 plakoustherapeutics.com Plakous Therapeutics extends research through agreement with Mayo Clinic WINSTON-SALEM, N.C., August 25, 2020โ Plakous โฆSee details»